Summary. Adenohypophysial cells having a glucocorticoid receptor were immunohistochemically determined in rats. For detecting the presence of the glucocorticoid receptor, we used the monoclonal antibody for a glucocorticoid receptor (BuGR-2), and immunohistochemically examined the phenotypes of the cells that exhibited BuGR-2-immunoreactivity.
The immunoreaction for the glucocorticoid receptor was confined to the nuclei of the majority of corticotrophs (70%) and of some somatotrophs in intact animals. Following adrenalectomy, all corticotrophs became significantly hypertrophic, losing their immunoreactivity for the glucocorticoid receptor. In contrast, somatotrophs that had also lost the immunoreactivity for the glucocorticoid receptor in the nuclei greatly diminished in size. Intraperitoneal administration of corticosterone was performed in adrenalectomized animals to supplement glucocorticoids. This treatment restored in the nuclei of some corticotrophs. In intact rats, immunolabeled corticotrophs were classified into two types, stellate and polyhedral. However, the immunoreaction for the glucocorticoid receptor was equally evident in the cell nuclei of these different types of cells. It is concluded that, in rats, both corticotrophs and somatotrophs are target cells of glucocorticoids, although these cell types display opposite growth responses to the removal of glucocorticoids.
Ever since the specific antibodies for the glucocorticoid receptor proteins became available in immunohistochemistry, the intracellular localization of the receptor has been able to be determined in neurons, in anterior pituitary cells, lymphatic tissues and liver cells at the light (PAPAMICHAIL et al., 1980; ANTAKLY and EISEN,1984; ANTAKLY et al., 1985; CINTRA et al., 1987; PICARD and YAMAMOTO,1987) and electron microscopic (LIPosITs et al., 1987) levels. In the hypothalamichypophysial-adrenal axis, glucocorticoids play the role of a mediator. Immunoreactivity for the glucocorticoid receptor has been detected not only in the neurons containing corticotrophic hormone-releasing hormone (CRF) in the hypothalamus (LIPosITs et al., 1987) , but also in various other neurons (FUxE et al., 1985; GUSTAFSSON et al., 1987; HIsAN0 et al., 1988) . In the anterior pituitary using a polyclonal antibody for the receptor protein, ANTAKLY et al. (1985) have shown that the immunoreactivity was present in almost all of the anterior pituitary cells. It has been presumed that the glucocorticoid receptor might be expressed in ACTH cells, but this has not yet been evidenced. In the present study, we have studied the phenotypes of cells containing glucocorticoid receptors in the rat anterior pituitary by employing a double Immunohistochemical staining method for the glucocorticoid receptor and each of the anterior pituitary hormones.
MATERIALS AND METHODS

Animals and experiments
Adult male Sprague-Dawley rats (240-300 g) were divided into six groups: normal, adrenalectomized, adrenalectomized and corticosterone-primed, shamadrenalectomized, corticosterone injected, and sesame-oil-injected control animals. Adrenalectomy was carried out bilaterally by a dorsal approach under ether anesthesia. The adrenalectomized rats were maintained on 0.9% saline ad libitum and killed 3 or 14 days after operation. Some of adrenalectomized rats were further treated with an intraperitoneal injection of corticosterone (10 mg/0.1 ml of ethanol and 0.9 ml of saline mixture/kg body weight) 4 h before sacrifice. Sham-operated rats were killed after 3 days. For 7 consecutive days, a large amount of corticosterone (50 mg/5 ml of sesame oil/kg body weight/day) was injected subcutaneously into 3 intact 104 R. YOKOTE, S. HISANO and S. DAIKOKU: animals. This dose of corticosterone has been previously shown to elevate blood steroid levels to those seen in response to major stressors (SAPOLSKY et al., 1985; O'CALLAGHAN et al., 1989) . As the controls, the same number of animals were treated with sesame oil. The animals thus treated were sacrificed 4 h after the last injection.
All the animals were killed by decapitation in the afternoon (13 : 00-15 : 00 h). The pituitaries were rapidly removed and immersed in a modified Zamboni's fixative (4% paraformaldehyde, 0.15% glutaraldehyde, and 0.2% picric acid in 0.1 M sodium cacodylate buffer, pH 7.4) for 2 h at room temperature and then overnight at 4C. The pituitaries were cut at a 50um thickness on a vibratome. These sections were washed in 0.02 M phosphate buffered saline (PBS), pH 7.4, and then processed for immunostaining with a monoclonal antibody against type II glucocorticoid receptor (BuGR-2) and with antisera to adenohypophysial hormones.
A polyclonal antiserum (B1-antiserum; kindly supplied by Prof. N. KATUNUMA, Division of Enzyme Chemistry, Institute for Enzyme Research, The University of Tokushima, Japan) generated against a part of the rat glucocorticoid receptor molecule was also used to stain the pituitary. The preparation procedures used to produce the serum correspond to those used by ANTAKLY and EISEN (1984) . The pituitaries were fixed in the abovementioned fixative or Bouin's solution without acetic acid, embedded in paraffin, and serially cut into sections 5um in thickness. The sections were double stainded with B1-antiserum and one of the antisera against pituitary hormones. These reactions were visualized by the avidin-biotin-peroxidase complex (ABC) method.
Antisera
The mouse monoclonal antibody BuGR-2 was kindly supplied by Dr. R. W. HARRISON, University of Arkansas for Medical Sciences. BuGR-2 was diluted to 1: 250 with 10% normal horse serum (Cappel, USA) in 0.02 M PBS, pH 7.4, containing 0.1% sodium azide. The generation and characterization of BuGR-2 raised by purified rat liver glucocorticoid receptor have been previously published (GAMETCHU and HARRISON, 1984; RISEN et al., 1985) . The staining specificity of the BuGR-2 was previously examined by the pre-absorption test (LIPosITs et al., 1987; UHT et al., 1988) .
For immunostaining the anterior pituitary hormones, we used the following antisera : anti-ACTH (1: 2000), -rat thyroid-stimulating hormone B-subunit (rTSHf) (1:10000), -rat growth hormone (rGH) (1: 5000), -rat prolactin (rPRL) (1: 5000), and -human chorionic gonadotropin (hCG) (1:4000). These antisera were diluted with 0.1 M phosphate buffer containing rat liver extract and bovine serum albumin (0.1%) to reduce background staining. The specificities of anti-ACTH (DAIKOKU et al., 1983 ), -rTSHf (DAIKOKU et al., 1981 ), -rPRL (HISANO et al., 1984 , and -hCG (DAIKOKU et al., 1980) were confirmed by preabsorption tests with the respective antigens. Anti-rGH (HAC-RT25-01-RBP85) was kindly supplied by Prof. K. WAKABAYASHI (Institute of Endocrinology, Gunma University, Japan). The specificity of anti-rGH serum was examined by a non-competitive binding test (WAKABAYASHI and TANAKA,1988) , and possible cross-reactions with PRL, gonadotropins, ACTH or TSH were excluded at a dilution of 1:200 of the serum. The staining specificity of the anti-rGH serum was further tested by using adjacent serial sections stained alternately with the anti-rGH and -rPRL sera. B1-antiserum was generated against the amino acid sequence, 407-423 (kind gift of Pharmacia LKB, Osaka, Japan), of the rat glucocorticoid receptor sequence predicted from cDNA isolated by MIESFELD et al. (1986) . Intact rabbits were immunized 5 times at a 3-week interval with 0.5 mg of the peptide linked to the keyhole limpet hemocyanin. The specificity of the B1-antiserum was tested by the Western blotting procedure. Intact and adrenalectomized rat liver tissues were separately homogenized with TEG buffer (10 mM Tes-KOH, pH 7.4, 1 mM EDTA, 50 mM NaC1,10% glycerol, 20 mM Na-molybdate) using Dounce homogenizer, and the supernatant of 100,000 x g centrifugation was referred to be cytosol. The cytosol (40 jig of protein) was subjected to SDS polyacrylamide gel electrophoresis (SDS-PAGE) using 4/20 gradient gel (Daiichi Chemical, Japan) running at 4C. Immunoblotting was carried out by transferring protein from gel to Immobilon (Millipore). After blocking the blotting with 3% bovine serum albumin in TBS (20 mM Tris-HC1, pH 7.5, 0.15 M NaCI, 0.1% Tween-20), the sheet was incubated with anti-receptor serum diluted to 1:100-500 with 1% bovine serum albumin in TBS for 4 h at room temperature and immunostained with picoBrue ImmunoDetection kit (Stratagene) according to the procedures suggested by the manufacturer.
The B1 -antiserum was further tested by an immunoadsorption test to determine the specific binding of the steroid. Liver cytosol prepared from the adrenalectomized rat was incubated with 50 nM [3H] -triamcinolone acetonide (TA) at 4C overnight with or without 1000-fold excess of nonradioactive dexamethasone. Free steroid was removed with charcoal and the specific' binding of glucocorticoids was then stirred at 4 for 2 h. Protein A sepharose was then pelleted by centrifugation and washed 4 times with 1 ml of TEG buffer containing 0.2% Tween-20. The final pellets were counted for radioactivity. The B1-antiserum was diluted to 1: 200 and used for immunostaining.
Immunocytochemical procedures
Vibratome sections of the anterior pituitary were treated according to the following schedule: 1) 0.2 Triton X-100 (Wako Pure Chemical Ind. LTD. Japan) in PBS at room temperature for 20 min; 2) 10% normal horse serum in PBS containing 0.5% lysine, 0.5% glycine and 0.1% sodium azide for 1 h at 18t; 3) BuGR-2, or 10% normal horse serum only (as a negative control of BuGR) for 60 h at 4t; 4) biotinylated horse anti-mouse IgG (1: 200, Vectastain ABC Kit, Vector Laboratories, USA) for 6 h at 18; and 5) incubation in ABC (Vectastain ABC Kit) diluted with Tris-buffered saline (TBS), pH 9.6, for 15 h at 4
After incubation with each solution, the sections were washed with PBS or TBS. The immunoreaction for the glucocorticoid receptor was visualized with 3,3'-diaminobenzidine tetrahydrochloride (DAB) by incubating the sections in the following solutions: 5 mg DAB and 40 mg glucose in 9.5 ml of PBS, and 200 j1 of 0.03% glucose oxidase aqueous solution. The tissue sections were incubated in this solution for 20 min at 35t ; thereby the immunoreaction for the glucocorticoid receptor was colored brown. The sections were rinsed several times in PBS.
Most of the stained vibratome sections were immersed in a warmed agar-gelatin mixture (5% wt/vol of Bacto-Agar, Difco, and 2% wt/vol of gelatin, Merk, in distilled water) for 1 min and flat embedded in the solidified mixture in a cold bath. The agargelatin blocks were cut into small pieces, dehydrated by an ascending ethanol series, embedded in paraffin in vacuo, and serially cut at a 5um thickness. These sections were mounted separately on different albumin-coated glass slides. Each section was then immunostained respectively with one of the antisera against the aforementioned adenohypophysial hormones. Immunostaining was performed as follows: 1) 3% hydrogen peroxide for 15 min at room temperature to eliminate endogenous peroxidase activities; 2) incubation with each antiserum overnight at 4t; 3) biotinylated goat anti-rabbit IgG (1: 200) (Vectastain ABC Kit) for 1 h at 32t ; and 4) ABC reagents (Vectastain ABC Kit) for 1 h at 32t . After each staining step, the sections were washed in distilled water for 10 min. DAB-Co ion solution was prepared by dissolving 20 mg of DAB in 40 ml of Tris-HCl buffer, 0.05 M, pH 7.6, and then by adding 0.4 ml of 1 % CoC12. The sections were incubated in the DABCo ion solution for 5 min, and for a further 2-3 min after adding 10ul of 3% H202 in the solution (Hsu and SOBAN, 1982) . Hence, the immunoreaction for each anterior pituitary hormone was blue, in sharp contrast with the brown immunoreaction for the glucocorticoid receptor.
The immunostaining with the B1-antiserum was performed in the same manner as that indicated in the immunostaining with anti-pituitary hormones. The staining specificity of the serum was examined by an absorption test of the serum after adding the antigen (1 or 10 jug/ml) to the antiserum.
Morphometric procedure
To estimate the morphological alterations of corticotrophs and somatotrophs, we determined the average areas of these cells of the intact, adrenal- ectomized (3 and 14 days postsurgery) and shamadrenalectomized (3 days postsurgery) animals by using a computerized superimposing system (software: Cosmozone-ISA, Nikon, Japan). An estimate of the volume of ACTH cells was difficult because they were morphologically irregular in intact animals. The sections were magnified by 1192.1-fold on a color display, and the cell outlines were traced on a magnetic tablet, by which the areas of the individual cells were put in a computer (PC-9801RX, NEC, Japan). We provided five animals for each experimental group, and estimated cell areas at random using sections through the central portion of the lateral lobes. Only cells containing the nucleus in the section were used for this measurement. The number of cells measured was 500 in each pituitary. The average cell areas were calculated, and the figures were statistically analyzed with Duncan's multiple range test. Statistical significance was accepted at P<0.05.
RESULTS
Immunostaining
with BuGR-2
The brown color of DAB-reaction product for the glucocorticoid receptor and the blue reaction with cobalt for the pituitary hormones made it possible to visualize co-expression in the same cell of the glucocorticoid receptor and peptides in single sections. In the anterior pituitary of male rats, the majority (about 70%) of ACTH cells and a minority of somatotrophs were immunoreactive for BuGR-2 (Fig. 1) , but others appeared to be negative. In immunoreactive cells, the immunoreaction was confined to within the nuclei (Fig. 1) .
BuGR-2-positive ACTH cells were predominantly small cells of stellate shape with several short and long processes and partly large polyhedral cells without prominent processes (Fig. 1) . The small stellate ACTH cells occasionally embraced immunoregative cells with their processes. Some of the larger polyhedral ACTH cells showed vacuolar structures in the cell body. On days 3 and 14 after adrenalectomy, the immunoreaction to BuGR-2 totally disappeared in the nuclei of anterior pituitary cells. ACTH cells became hypertrophic and appeared polyhedral or spherical rather than stellate in shape (Fig. 1) , the cytoplasmic processes no longer embracing other cells. Immunostainability for ACTH became fainter 3 days after adrenalectomy, but recovered to the same level as the intact animals on day 14 (Fig. 1) . The cell bodies, however, revealed numerous fine vacuolar structures (Fig. 1) . The average cell areas of corticotrophs were 122.6+4.0 pmt and 144.7+3.8 Um2 for the intact control and the sham-adrenalectomi zed animals, respectively. They were 172.4+2.9 Acme and 181.4+3.8 'Um2 3 and 14 days after adrenalectomy (Fig. 2) . The average cell areas of somatotrophs were 100.6+1.8pm2 and 99.3+1.7 pmt for the intact control and the sham-adrenalectomized animals, respectively. After adrenalectomy, the areas were significantly reduced to 87.6+1.4um2 and 89.4+1.5 pmt at 3 and 14 days postsurgery (Fig. 2) . Other anterior pituitary cells did not show distinct alterations in morphology.
After corticosterone replacement in adrenalectomized animals, we found only a slight recovery of stainability for BuGR-2 in the nuclei of ACTH cells. Immunoreaction to BuGR-2 was no longer evident after administrating corticosterone to the intact animals for seven days. The major ACTH cells were the polyhedral ones, whereas the stellate ones were rather minor in population. However, no morphological difference could be recognized in somatotrophs between the control and the corticosteroneadministered rats. The BuGR-2 reaction was not evident in the nucleus. The monospecificity of B,-antiserum was confirmed by the Western blot analysis; the glucocorticoid receptor (93 kDa) was detected as a single band. Pretreatment of the antiserum with antigenic peptide diminished the 93 kDa receptor band (data not shown), and an intensified band was visible in the cytosol of the adrenalectomized rat (Fig. 3, lane 2) .
Immunostaining with B,-antiserum
The immunoreaction for the B,-antiserum was confined to cellular nuclei, and found in almost all anterior pituitary cells (Fig. 4) . However, a few cells also displayed the immunoreaction in the cytoplasm. In adjacent serial sections stained alternately with the B,-antiserum and with anti-ACTH serum, the number of B,-positive cells exceeded that of ACTHpositive cells. Immunonegative cells, though few, were scattered throughout the tissue; their exact type could not be defined. Fourteen days after adrenalectomy, the immunoreaction became faint, but did not completely disappear as the BuGR reaction did. The nuclear and cytoplasmic staining became weaker and finally indistinct with the B,-antiserum pre-absorbing with 1 or 10 ug/ml of the corresponding antigen.
DISCUSSION
The present study is the first to show that, in the rat anterior pituitary, ACTH cells and somatotrophs are immunoreactive for the glucocorticoid receptor and that morphological alterations occur in these cells following adrenalectomy and corticosteroneadministration.
These findings suggest that the cells are the targets of corticosteroids.
As is well known, glucocorticoid secretion from the adrenal gland is under the regulation of CRFcontaining neurons and ACTH cells. ACTH released from ACTH cells in the adenohypophysis stimulates the secretion of glucocorticoids, and these in turn exert negative feedback effects on both the hypothalamus (ENDROCZI et al.,1961; METES and URQUHART, 1962) and adenohypophysis (RUSSELL et al., 1969; MULDER and SMELIK, 1977) . These feedback effects are thought to be mediated by the glucocorticoid receptor (GUSTAFSSON et al., 1983) .
In the hypothalamus, it has been shown that CRFcontaining neurons are the sites of this feedback action, as the presence of glucocorticoid receptor in these neurons has been demonstrated (CINTRA et al., 1987; UHT et al., 1988) . However, evidence is lacking in the adenohypophysis to accurately determine the feedback sites of glucocorticoids. Autoradiographic studies have demonstrated that some anterior pituitary cells incorporate radiolabeled glucocorticoids in their nuclei (REFS et al., 1975) . Recent immunohistochemical studies (ANTAKLY and EISEN, 1984) have reported that the glucocorticoid receptor might occur in essentially all anterior pituitary cell nuclei and in some cell bodies. These authors used a polyclonal antibody for the glucocorticoid receptor obtained from liver cells (EISEN, 1980; EISEN et al., 1981) , and emphasized that immunoreactive cells exceeded in number the corticotrophs, as identified by immunocytochemistry of ACTH. The same was obtained in our study using the B1-antiserum. The immunoreaction for the B1-antiserum was localized in the nuclei of almost all anterior pituitary cells, but in the cytoplasm of only a few cells. The immunoreaction became faint after adrenalectomy but did not completely disappear as found in BuGR-2 staining. In the staining with the B1-antiserum pre-absorbed with the antigen, the nuclear and cytoplasmic immunoreactions became weaker and finally indistinct. These findings suggest that the B1-antiserum may crossreact with certain peptides, although the serum is immunologically monospecific against the amino acid sequence 407-423 of rat glucocorticoid receptor protein.
In contrast with the findings obtained by using the B1-antiserum, the staining with BuGR-2 allowed us to demonstrate a glucocorticoid receptor in the nuclei of ACTH and GH cells. It seems, thus, that the localizations of the monoclonal and polyclonal antibodies are not identical, although they are exclusively confined in cell nuclei. A polyclonal antibody for corticosteroid-binding globulin prepared by PERROT-APPLANAT et al. (1984) demonstrated the immunoreactivity in the cell bodies of corticotrophs.
Most recently, ANTAKLY and his coworkers (1990) raised an antiserum to a synthetic peptide of the N-terminal domain of human glucocorticoid receptor, and stained cell bodies of the anterior pituitary, but did not indicate the sort of cells.
Evidence has accumulated supporting the responsiveness of adenohypophysial cells to glucocorticoids. Glucocorticoids affect ACTH mRNA activity by modifying ACTH synthesis (NAKANISHI et al., 1977; LIM et al.,1982; KELLER-WOOD et al., 1984; WIDMAIER and DALLMAN, 1984; ABOU-SAMRA et al., 1986; CEDA and HOFFMAN, 1986; LEVIN et al., 1988; DAYANITHI and ANTONI, 1989; FAMILARI and FUNDER, 1989) . Several works have also shown some effects of glucocorticoids on somatotrophs (MARTIAL et al., 1977; EVANS et al., 1982; WEHRENBERG et al., 1983; SEIFERT et al., 1985; CEDA et al., 1987) .
It has recently been shown by in situ hybridization that the GH mRNA level is influenced by glucocorticoids (MARTINOLI and PELLETIER, 1989) . In accordance with these findings, the nuclear localization of the glucocorticoid receptor and the morphological alterations of cells presented here indicate that the sites of glucocorticoid action in the pituitary are ACTH cells and somatotrophs. Noteworthy, thereby, is the fact that the cell size changes that occurred in both cell types were reverse. The responsiveness of ACTH cells to adrenalectomy has been studied repeatedly by many investigators (CHILDS et al., 1983; WESTLUND et al., 1985) . This is the first report on the immunoreactivity for glucocorticoid receptor occurring in the nuclei of somatotrophs of intact animals and on the morphological alteration of somatotrophs in the adrenalectomized animals. Physiological studies have revealed the presence of stimulatory effects of corticosterone on somatotroph secretion (KOHLER et al., 1968 (KOHLER et al., , 1969 BANCROFT et al., 1969) . Glucocorticoid treatment results in elevated plasma GH concentrations (WEHRENBERG et al., 1983; MOSIER and JAN-SONS, 1985) . CEDA et al. (1987) have shown that the effects of glucocorticoids on GH secretion are biphasic. During short incubations in a medium of the hypothalamus-hypophysis complex, dexamethasone placed in the medium inhibits GH-releasing hormone (GHRH) secretion and forskolin-elicited GH secretion, but during longer incubation, glucocorticoids enhance both basal and GHRH-stimulated GH release. Our morphometric data show that GH cells respond to adrenalectomy with a significant reduc-tion in size. If glucocorticoids elevate GH mRNA levels (MARTINOLI and PELLETIER,1989) and enhance the responsiveness of GH cells to GHRH (VALE et al., 1983) , this size decrease of the GH-cell seems to be consistent with the lowered synthesis of GH in the cells. It is of particular interest that hypothalamic GHRH-containing neurons also express a glucocorticoid receptor in rats (CINTRA et al., 1987) .
From a morphological viewpoint, ACTH cells can be classified into two types, depending on the morphology of the secretory granules (MORIARTY and HALMI, 1972; BOWIE et al., 1973; YOSHIMURA and NOGAMI, 1981; KUROSUMI et al., 1984) . The larger polyhedral type and small stellate type have been classified as types II and I, respectively, by KUROSUMI and coworkers (1984) . Our findings, however, show that both types are equally BuGR-2-positive. Our results moreover evidence that, in adrenalectomized animals, the small stellate cells change to the large polyhedral ones. 
